Nukkleus Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2022	2021	2020	2019
Cash & Equivalents	0.36	0.4	0.71	0.03
Short-Term Investments	0.11	0	46	-
Cash & Cash Equivalents	0.47	0.4	46.72	0.03
Cash Growth	16.75%	-99.13%	168555.44%	-
Receivables	0.93	2.68	0	0
Other Current Assets	2.28	1.98	0.01	-
Total Current Assets	3.69	5.06	46.73	-
Long-Term Investments	6.6	0	0	-
Goodwill and Intangibles	8.08	10.75	0	0
Total Long-Term Assets	14.68	10.75	0	-
Total Assets	18.36	15.81	46.73	0.21
Accounts Payable	4.57	4.69	0.03	0
Current Debt	0	0	0.24	0.18
Other Current Liabilities	2.91	1.97	0.06	0.02
Total Current Liabilities	7.47	6.66	0.33	0.21
Other Long-Term Liabilities	0	0	0.25	0
Total Long-Term Liabilities	0	0	0.25	0
Total Liabilities	7.47	6.66	0.58	0.21
Total Debt	0	0	0.24	0.18
Debt Growth	-	-	34.10%	-
Retained Earnings	-14.34	-2.5	-3.73	-0.02
Comprehensive Income	0.06	0.01	0	0
Shareholders' Equity	10.89	9.16	0.15	0
Net Cash / Debt	0.47	0.4	46.47	-0.15
Net Cash / Debt Growth	16.75%	-99.13%	-	-
Net Cash Per Share	0.10	0.07	12.57	-
Working Capital	-3.79	-1.59	46.4	-
Book Value Per Share	2.40	1.50	0.04	0.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).